Active substances
- Cell-associated live recombinant turkey herpesvirus (strain HVT/ILT-138), expressing the glycoproteins gD and gI of infectious laryngotracheitis virus
- Cell-associated live recombinant turkey herpesvirus (strain HVT/NDV/ILT) expressing the fusion protein of newcastle disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus
- Cemiplimab
- cenobamate
- ceritinib
- cerliponase alfa
- Certolizumab pegol
- cetrorelix (as acetate)
- cetuximab
- ChAdOx1-SARS-COV-2
- characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
- Chenodeoxycholic acid
- chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live,
- Chlormethine
- cholic acid
- chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
- choriogonadotropin alfa
- ciclesonide
- ciclosporin
- cidofovir